PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
13-Jan-2026 Astoriom Appoints Will Edwards as Chief Executive Officer Astoriom
13-Jan-2026 Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines NanoSyrinx
13-Jan-2026 Enara Bio enters 2026 with Dark Antigen licensing to Boehringer Ingelheim, appointment of Chief Medical Officer and plans to advance DARKFOX T-cell engager into First-in-Human studies Enara Bio
13-Jan-2026 Neuraxpharm enhances ADHD treatment options in Europe with launches of Tuzulby® chewable tablets and Paxneury® Neuraxpharm
13-Jan-2026 Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies Domain Therapeutics, Kainova Therapeutics
13-Jan-2026 Immuthera Announces Global Exclusive License from City of Hope for First-in-Class CD6/CTLA-4 CAR-Treg Platform for Autoimmune and Inflammatory Diseases Immuthera
13-Jan-2026 Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones Microbot Medical
13-Jan-2026 Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures Biocartis
13-Jan-2026 Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials Hongene
13-Jan-2026 Regulatory T-Cell (Tregs) Therapies Market Size to Reach USD 320.4 million in 2032 Navistrat Analytics
12-Jan-2026 Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV) shilpa medicare
12-Jan-2026 Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months Aragen
12-Jan-2026 Jubilant Biosys Doubles Early Chemistry Scale-up Capacity with New Noida Facility in India Jubilant Biosys Limited
12-Jan-2026 Bio-Sourcing and Zerion Pharma join forces to develop first HER2 oral monoclonal antibody against breast cancer Andrew Lloyd Associates
08-Jan-2026 Paul Billings Joins Lindus Health’s Scientific Advisory Board Lindus Health
08-Jan-2026 CellVoyant launches new online predictive cell analytics platform to fast-track drug development CellVoyant
08-Jan-2026 Enodia Therapeutics Secures €20.7M to Advance a Small-Molecule Platform for Targeted Protein Degradation Enabled by Proteomics and Machine Learning Enodia Therapeutics
08-Jan-2026 Alceus Bio awarded Pioneer Group and AbbVie’s Golden Ticket Alceus Bio , Abbvie, Pioneer Group
08-Jan-2026 Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector Celltrion
08-Jan-2026 STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications STORM Therapeutics